Repligen (RGEN) Tops Q1 EPS by 11c, Revenues Beat; Raises FY20 EPS Guidance Above Consensus, Reaffirms Revenue Views Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Repligen Corp (NASDAQ: RGEN) | Delayed: 179.50 +1.23 (0.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $178.27 | 52 Week High | $33.79 | |||
| Open | $183.40 | 52 Week Low | $20.07 | |||
| Day High | $188.50 | P/E | 256.43 | |||
| Day Low | $174.39 | EPS | $0.70 | |||
| Volume | 812,537 | |||||
